CHRIS OLMSTEAD: Open Payments
NPI 1134817596 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 88 payments from 20 companies in 2025. Trend: 2023 $663 · 2024 $1,039 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $250 |
| ABBVIE INC. | 22 | $223 |
| PFIZER INC. | 13 | $183 |
| Corcept Therapeutics | 7 | $174 |
| Phathom Pharmaceuticals, Inc. | 6 | $147 |
| Lilly USA, LLC | 7 | $129 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
Products named: Ozempic, Korlym, PREVNAR 20, VOQUEZNA, JARDIANCE, QULIPTA, CAPLYTA, VRAYLAR.
Industry payments across WA — which companies pay providers there.
